Welcome to THAOS

The Transthyretin Amyloidosis Outcomes Survey (THAOS), established in 2007, is a longitudinal, observational study open to all physicians treating, and all individuals diagnosed with, or carrying a mutation that puts them at risk of transthyretin (TTR) amyloidosis. The data collected by THAOS will be used to inform and educate clinicians about the disease and its management.

The THAOS.net website provides information for patients, their caregivers and physicians about TTR amyloidosis.

Latest
News
Bulletin

THAOS data to be presented at ISA 2018 in Kumamoto, Japan.2017 THAOS Investigator and Scientific Board meetings held in Rome, Italy, October 7-9th, 2017.